Tvardi Therapeutics (TVRD) files $200M mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Form S-3 Tvardi Therapeutics,
May 1, 2026 4:06 PM EDTTABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 1, 2026 Registration No. 333- UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C.... More

